| Discovery | Candidate | Preclinical | Phase I | Partner | |
|---|---|---|---|---|---|
| GPCR target for metabolic diseases + |
Discovery
|
||||
| EP4 receptor antagonist (DT-9081) + | Phase I | ||||
| A2aR/A2bR antagonist (M1069) + |
Phase I
|
||||
| Anti-CCR8 depleting antibody (DT-7012) + | Preclinical | ||||
| PAR2 antagonist (DT-9045) + | Preclinical | ||||
| Undisclosed GPCR targets + | Discovery | ||||
| mGluR4/7/8 PAM (DT-095435) + | Candidate | ||||
| NPFFR antagonist + | Discovery | ||||
| Multi-target collaboration for rare diseases + |
Discovery
|
||||
| CXCR4 biased agonist + |
Discovery
|
||||
